Meeting
2016 Genitourinary Cancers Symposium
Prognostic role of body mass index (BMI) in patients with metastatic castration resistant prostate cancer (mCRPC) receiving chemotherapy: Preliminary results from a retrospective Italian multicenter study.
Authors
Stefania Eufemia Lutrino
Perrino Hospital, Brindisi, Italy
Stefania Eufemia Lutrino , Caterina Fontanella , Orazio Caffo , Francesco Massari , Francesco Atzori , Claudia Maggi , Nicola Calvani , Cosimo Sacco , Antonello Veccia , Alessandra Modena , Silvia Cugudda , Elena Verzoni , Chiara Caliolo , Paola Ermacora , Francesca Maines , Giampaolo Tortora , Giuseppe Procopio , Pasqualinda Ferrara , Gianpiero Fasola , Saverio Cinieri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 342)
DOI
10.1200/jco.2016.34.2_suppl.342
Abstract #
342
Poster Bd #
E4
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Association of changes in measurable disease by RECIST with survival in metastatic castration-resistant prostate cancer (mCRPC).
First Author: Guru Sonpavde
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Associations between BMI, morphomics and survival in 528 patients with metastatic pancreatic cancer.
First Author: Valerie Gunchick
Poster
2023 ASCO Annual Meeting
Concurrent chemo-hormonal therapy of enzalutamide (ENZ) and cabazitaxel (CAB) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC): Final analysis of objective response rate (ORR), radiographic progression-free survival (rPFS), and overall survival (OS).
First Author: Alexandra Sokolova
Poster
2023 ASCO Genitourinary Cancers Symposium
Prognostic value of pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.
First Author: Zhipeng Wang